376 related articles for article (PubMed ID: 32709019)
21. Inhibition of NAD+ glycohydrolase and ADP-ribosyl cyclase activities of leukocyte cell surface antigen CD38 by gangliosides.
Hara-Yokoyama M; Kukimoto I; Nishina H; Kontani K; Hirabayashi Y; Irie F; Sugiya H; Furuyama S; Katada T
J Biol Chem; 1996 May; 271(22):12951-5. PubMed ID: 8662799
[TBL] [Abstract][Full Text] [Related]
22. The lymphocyte surface antigen CD38 acts as a nicotinamide adenine dinucleotide glycohydrolase in human T lymphocytes.
Gelman L; Deterre P; Gouy H; Boumsell L; Debré P; Bismuth G
Eur J Immunol; 1993 Dec; 23(12):3361-4. PubMed ID: 8258350
[TBL] [Abstract][Full Text] [Related]
23. The balance between NAD
Strømland Ø; Diab J; Ferrario E; Sverkeli LJ; Ziegler M
Mech Ageing Dev; 2021 Oct; 199():111569. PubMed ID: 34509469
[TBL] [Abstract][Full Text] [Related]
24. Evidence for an intracellular ADP-ribosyl cyclase/NAD+-glycohydrolase in brain from CD38-deficient mice.
Ceni C; Muller-Steffner H; Lund F; Pochon N; Schweitzer A; De Waard M; Schuber F; Villaz M; Moutin MJ
J Biol Chem; 2003 Oct; 278(42):40670-8. PubMed ID: 12909645
[TBL] [Abstract][Full Text] [Related]
25. NAD and the aging process: Role in life, death and everything in between.
Chini CCS; Tarragó MG; Chini EN
Mol Cell Endocrinol; 2017 Nov; 455():62-74. PubMed ID: 27825999
[TBL] [Abstract][Full Text] [Related]
26. CD38: A Potential Therapeutic Target in Cardiovascular Disease.
Zuo W; Liu N; Zeng Y; Liu Y; Li B; Wu K; Xiao Y; Liu Q
Cardiovasc Drugs Ther; 2021 Aug; 35(4):815-828. PubMed ID: 32472237
[TBL] [Abstract][Full Text] [Related]
27. Interaction of two classes of ADP-ribose transfer reactions in immune signaling.
Han MK; Cho YS; Kim YS; Yim CY; Kim UH
J Biol Chem; 2000 Jul; 275(27):20799-805. PubMed ID: 10777496
[TBL] [Abstract][Full Text] [Related]
28. Connexin-43 hemichannels mediate cyclic ADP-ribose generation and its Ca2+-mobilizing activity by NAD+/cyclic ADP-ribose transport.
Song EK; Rah SY; Lee YR; Yoo CH; Kim YR; Yeom JH; Park KH; Kim JS; Kim UH; Han MK
J Biol Chem; 2011 Dec; 286(52):44480-90. PubMed ID: 22033928
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of cardiomyocytes differentiation of mouse embryonic stem cells by CD38/cADPR/Ca2+ signaling pathway.
Wei WJ; Sun HY; Ting KY; Zhang LH; Lee HC; Li GR; Yue J
J Biol Chem; 2012 Oct; 287(42):35599-35611. PubMed ID: 22908234
[TBL] [Abstract][Full Text] [Related]
30. Role of CD38/cADPR signaling in obstructive pulmonary diseases.
Guedes AG; Dileepan M; Jude JA; Deshpande DA; Walseth TF; Kannan MS
Curr Opin Pharmacol; 2020 Apr; 51():29-33. PubMed ID: 32480246
[TBL] [Abstract][Full Text] [Related]
31. CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD
Chmielewski JP; Bowlby SC; Wheeler FB; Shi L; Sui G; Davis AL; Howard TD; D'Agostino RB; Miller LD; Sirintrapun SJ; Cramer SD; Kridel SJ
Mol Cancer Res; 2018 Nov; 16(11):1687-1700. PubMed ID: 30076241
[TBL] [Abstract][Full Text] [Related]
32. CD38 activation by monosodium urate crystals contributes to inflammatory responses in human and murine macrophages.
Wen S; Arakawa H; Tamai I
Biochem Biophys Res Commun; 2021 Dec; 581():6-11. PubMed ID: 34637964
[TBL] [Abstract][Full Text] [Related]
33. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism.
Camacho-Pereira J; Tarragó MG; Chini CCS; Nin V; Escande C; Warner GM; Puranik AS; Schoon RA; Reid JM; Galina A; Chini EN
Cell Metab; 2016 Jun; 23(6):1127-1139. PubMed ID: 27304511
[TBL] [Abstract][Full Text] [Related]
34. CD38 Knockout Mice Show Significant Protection Against Ischemic Brain Damage Despite High Level Poly-ADP-Ribosylation.
Long A; Park JH; Klimova N; Fowler C; Loane DJ; Kristian T
Neurochem Res; 2017 Jan; 42(1):283-293. PubMed ID: 27518087
[TBL] [Abstract][Full Text] [Related]
35. Blocking the CD38/cADPR pathway plays a double-edged role in LPS stimulated microglia.
Wang YM; Liu ZY; Ai YH; Zhang LN; Zou Y; Peng QY
Neuroscience; 2017 Oct; 361():34-42. PubMed ID: 28807785
[TBL] [Abstract][Full Text] [Related]
36. NAD(P)H oxidase-dependent intracellular and extracellular O2•- production in coronary arterial myocytes from CD38 knockout mice.
Xu M; Zhang Y; Xia M; Li XX; Ritter JK; Zhang F; Li PL
Free Radic Biol Med; 2012 Jan; 52(2):357-65. PubMed ID: 22100343
[TBL] [Abstract][Full Text] [Related]
37. CD38-NAD
Chatterjee S; Daenthanasanmak A; Chakraborty P; Wyatt MW; Dhar P; Selvam SP; Fu J; Zhang J; Nguyen H; Kang I; Toth K; Al-Homrani M; Husain M; Beeson G; Ball L; Helke K; Husain S; Garrett-Mayer E; Hardiman G; Mehrotra M; Nishimura MI; Beeson CC; Bupp MG; Wu J; Ogretmen B; Paulos CM; Rathmell J; Yu XZ; Mehrotra S
Cell Metab; 2018 Jan; 27(1):85-100.e8. PubMed ID: 29129787
[TBL] [Abstract][Full Text] [Related]
38. Revealing CD38 cellular localization using a cell permeable, mechanism-based fluorescent small-molecule probe.
Shrimp JH; Hu J; Dong M; Wang BS; MacDonald R; Jiang H; Hao Q; Yen A; Lin H
J Am Chem Soc; 2014 Apr; 136(15):5656-63. PubMed ID: 24660829
[TBL] [Abstract][Full Text] [Related]
39. CD38 and MGluR1 as possible signaling molecules involved in epileptogenesis: A potential role for NAD
Khodaverdian S; Dashtban-Moghadam E; Dabirmanesh B; Mirnajafi-Zadeh J; Taleb M; Khajeh K; Fathollahi Y
Brain Res; 2021 Aug; 1765():147509. PubMed ID: 33930374
[TBL] [Abstract][Full Text] [Related]
40. CD38 in bovine lung: A multicatalytic NADase.
Polzonetti V; Pucciarelli S; Vita A; Vincenzetti S; Natalini P
J Membr Biol; 2009 Feb; 227(3):105-10. PubMed ID: 19169615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
